Inventor · disambiguated record
Joseph Farthing
Also filed as: FARTHING JOSEPH · FARTHING JOSEPH S
13 granted patents·14 pending applications·96 citations·filing 2016–2025
91Inventor score
Files withCRITITECH INC27
Top patents by PatentIndex Score
27 records- 0197US9814685B2Taxane particles and their useCRITITECH INC·Filed 2016·Granted Nov 14, 2017·40 cites·18 claims
- 0296US10729673B2Taxane particles and their useCRITITECH INC·Filed 2020·Granted Aug 4, 2020·11 cites·22 claims
- 0396US9918957B2Methods for making compound particlesCRITITECH INC·Filed 2017·Granted Mar 20, 2018·23 cites·18 claims
- 0495US10507195B2Taxane particles and their useCRITITECH INC·Filed 2018·Granted Dec 17, 2019·18 cites·28 claims
- 0591US11123322B2Taxane particles and their useCRITITECH INC·Filed 2019·Granted Sep 21, 2021·2 cites·18 claims
- 0690US2025186390A1Taxane Particles and Their UseCRITITECH INC·Filed 2024·Application pending·0 cites
- 0786US10993927B2Taxane particles and their useCRITITECH INC·Filed 2020·Granted May 4, 2021·1 cites·18 claims
- 0882US10751319B2Collection device and methods for useCRITITECH INC·Filed 2016·Granted Aug 25, 2020·1 cites·14 claims
- 0979US2021393569A1Taxane Particles and Their UseCRITITECH INC·Filed 2021·Application pending·0 cites
- 1074US2024226116A1Glucocorticoid Particles and Their UseCRITITECH INC·Filed 2024·Application pending·0 cites
- 1174US2020405684A1Taxane Particles and Their UseCRITITECH INC·Filed 2020·Application pending·0 cites
- 1273US12029818B2Lapatinib particles and uses thereofCRITITECH INC·Filed 2022·Granted Jul 9, 2024·0 cites·17 claims
- 1370US2025360166A1Cisplatin particles and uses thereofCRITITECH INC·Filed 2025·Application pending·0 cites
- 1468US11738014B2Niraparib particles and uses thereofCRITITECH INC·Filed 2022·Granted Aug 29, 2023·0 cites·17 claims
- 1568US11738029B2Rucaparib particles and uses thereofCRITITECH INC·Filed 2022·Granted Aug 29, 2023·0 cites·17 claims
- 1668US11291646B2Nozzle assembly and methods for useCRITITECH INC·Filed 2016·Granted Apr 5, 2022·0 cites·22 claims
- 1767US11931368B2Glucocorticoid “nintedanib” particles and their useCRITITECH INC·Filed 2018·Granted Mar 19, 2024·0 cites·8 claims
- 1866US11104663B2Ciprofloxacin polymorph and its useCRITITECH INC·Filed 2018·Granted Aug 31, 2021·0 cites·19 claims
- 1965US2024216424A1Cisplatin particles and uses thereofCRITITECH INC·Filed 2022·Application pending·0 cites
- 2063US2016374953A1Methods for Making Compound ParticlesCRITITECH INC·Filed 2016·Application pending·0 cites
- 2163US2021387961A1Ciprofloxacin polymorph and its useCRITITECH INC·Filed 2021·Application pending·0 cites
- 2262US2024156861A1Cisplatin particles and uses thereofCRITITECH INC·Filed 2023·Application pending·0 cites
- 2362US2023364021A1Sorafenib particles and uses thereofCRITITECH INC·Filed 2023·Application pending·0 cites
- 2461US2022023215A1Lapatinib particles and uses thereofCRITITECH INC·Filed 2021·Application pending·0 cites
- 2554US2023414510A1Niclosamide particles and uses thereofCRITITECH INC·Filed 2021·Application pending·0 cites
- 2652US2022241257A1Sorafenib particles and uses thereofCRITITECH INC·Filed 2021·Application pending·0 cites
- 2744US2018353630A1System and Methods for Tissue SterilizationCRITITECH INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph Farthing files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →